carbon monoxide has been researched along with Autoimmune Diabetes in 28 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cough was the most common adverse event; however, there was no difference in incidence between the AIR insulin (15." | 2.74 | Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial. ( Ang, E; Berclaz, PY; Ferguson, JA; Heilmann, CR; Lawrence, MK; Tobian, JA; Webb, DM, 2009) |
| " Adverse events were comparable between groups." | 2.71 | Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. ( Bélanger, A; Bohannon, NJ; Quattrin, T; Schwartz, SL, 2004) |
| "Carbon monoxide (CO) treatment improves pathogenic outcome of autoimmune diseases by promoting tolerance." | 1.39 | Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes. ( Anegon, I; Bach, JM; Blancou, P; Piaggio, E; Pogu, S; Rémy, S; Rigaud, K; Simon, T; Tardif, V, 2013) |
| "Forty patients with Type 1 diabetes, 20 with autonomic neuropathy according to the results of a standardized test battery, were studied and compared with 40 normal subjects matched by age and sex." | 1.37 | Pulmonary diffusing capacity for carbon monoxide: a marker of depressed hypercapnic drive in type 1 diabetes mellitus? ( Antonelli Incalzi, R; Contu, C; Fuso, L; Ghirlanda, G; Maugeri, L; Musella, T; Paladini, L; Pitocco, D; Santamaria, AP; Varone, F, 2011) |
| "We studied 39 children with type 1 diabetes (mean age 10." | 1.32 | Diffusing capacity for carbon monoxide in children with type 1 diabetes. ( Barreto, M; Montesano, M; Multari, G; Pagani, J; Ronchetti, R; Stegagno, M; Villa, MP, 2004) |
| "Eighteen subjects with IDDM and 14 normal control subjects were studied." | 1.30 | Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. ( Hsia, CC; McBrayer, DG; Niranjan, V; Ramirez, LC; Raskin, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 12 (42.86) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Peng, SY | 1 |
| Hong, S | 1 |
| Chen, QW | 1 |
| Zeng, X | 1 |
| Rong, L | 1 |
| Zhong, ZL | 1 |
| Zhang, XZ | 1 |
| Mishra, M | 1 |
| Ndisang, JF | 2 |
| Tiwari, S | 1 |
| Nikolic, I | 1 |
| Saksida, T | 1 |
| Mangano, K | 1 |
| Vujicic, M | 1 |
| Stojanovic, I | 1 |
| Nicoletti, F | 1 |
| Stosic-Grujicic, S | 1 |
| Vojtková, J | 1 |
| Ďurdík, P | 1 |
| Michnová, Z | 1 |
| Turčan, T | 1 |
| Čiljaková, M | 1 |
| Rodella, LF | 1 |
| Vanella, L | 1 |
| Peterson, SJ | 1 |
| Drummond, G | 1 |
| Rezzani, R | 2 |
| Falck, JR | 2 |
| Abraham, NG | 4 |
| Ang, E | 1 |
| Lawrence, MK | 1 |
| Heilmann, CR | 1 |
| Ferguson, JA | 1 |
| Tobian, JA | 1 |
| Webb, DM | 1 |
| Berclaz, PY | 1 |
| Rodriguez, F | 1 |
| Lopez, B | 1 |
| Perez, C | 1 |
| Fenoy, FJ | 1 |
| Hernandez, I | 1 |
| Stec, DE | 1 |
| Li Volti, G | 1 |
| Salom, MG | 1 |
| Fuso, L | 2 |
| Paladini, L | 1 |
| Pitocco, D | 2 |
| Musella, T | 1 |
| Contu, C | 1 |
| Maugeri, L | 1 |
| Santamaria, AP | 1 |
| Varone, F | 1 |
| Ghirlanda, G | 2 |
| Antonelli Incalzi, R | 2 |
| Scaramuzza, AE | 1 |
| Morelli, M | 1 |
| Rizzi, M | 1 |
| Borgonovo, S | 1 |
| De Palma, A | 1 |
| Mameli, C | 1 |
| Giani, E | 1 |
| Beretta, S | 1 |
| Zuccotti, GV | 1 |
| Simon, T | 1 |
| Pogu, S | 1 |
| Tardif, V | 1 |
| Rigaud, K | 1 |
| Rémy, S | 1 |
| Piaggio, E | 1 |
| Bach, JM | 1 |
| Anegon, I | 1 |
| Blancou, P | 1 |
| Masmoudi, K | 1 |
| Choyakh, F | 1 |
| Zouari, N | 1 |
| Bach, FH | 1 |
| Quattrin, T | 1 |
| Bélanger, A | 1 |
| Bohannon, NJ | 1 |
| Schwartz, SL | 1 |
| Villa, MP | 1 |
| Montesano, M | 1 |
| Barreto, M | 1 |
| Pagani, J | 1 |
| Stegagno, M | 1 |
| Multari, G | 1 |
| Ronchetti, R | 1 |
| Kappas, A | 2 |
| Rodella, L | 1 |
| Lamon, BD | 1 |
| Sangras, B | 1 |
| Goodman, AI | 1 |
| Dunn, C | 1 |
| Curran, MP | 1 |
| Basso, S | 1 |
| Trové, A | 1 |
| Longobardi, A | 1 |
| Calcagni, ML | 1 |
| Giordano, A | 1 |
| Li, M | 1 |
| Peterson, S | 1 |
| Husney, D | 1 |
| Inaba, M | 1 |
| Guo, K | 1 |
| Terada, E | 1 |
| Morita, T | 1 |
| Patil, K | 1 |
| Ikehara, S | 1 |
| Niranjan, V | 1 |
| McBrayer, DG | 1 |
| Ramirez, LC | 2 |
| Raskin, P | 2 |
| Hsia, CC | 1 |
| Paredi, P | 1 |
| Biernacki, W | 1 |
| Invernizzi, G | 1 |
| Kharitonov, SA | 1 |
| Barnes, PJ | 1 |
| Scano, G | 1 |
| Filippelli, M | 1 |
| Romagnoli, I | 1 |
| Mancini, M | 1 |
| Misuri, G | 1 |
| Duranti, R | 1 |
| Rosi, E | 1 |
| Dal Nogare, A | 1 |
| Hsia, C | 1 |
| Arauz, C | 1 |
| Butt, I | 1 |
| Strowig, SM | 1 |
| Schnurr-Breen, L | 1 |
| Maccioni, FJ | 1 |
| Colebatch, HJ | 1 |
| Cooper, BG | 1 |
| Taylor, R | 1 |
| Alberti, KG | 1 |
| Gibson, GJ | 1 |
| Britton, J | 1 |
| Sandler, M | 1 |
| Bunn, AE | 1 |
| Stewart, RI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma[NCT00157339] | Phase 3 | 299 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for carbon monoxide and Autoimmune Diabetes
| Article | Year |
|---|---|
A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes.
Topics: Animals; Bilirubin; Biliverdine; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 2014 |
The heme oxygenase system and type-1 diabetes.
Topics: Animals; Bilirubin; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heme Oxyg | 2014 |
Heme oxygenase-1 as a protective gene.
Topics: Angioplasty, Balloon; Animals; Bilirubin; Carbon Monoxide; Diabetes Mellitus, Type 1; Graft Rejectio | 2002 |
Heme oxygenase and the cardiovascular-renal system.
Topics: Angioplasty, Balloon; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Bilirubin; Carbon Monoxide | 2005 |
2 trials available for carbon monoxide and Autoimmune Diabetes
| Article | Year |
|---|---|
Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
Topics: Administration, Inhalation; Adult; Age of Onset; Aged; Asthma; Body Mass Index; Carbon Monoxide; Dia | 2009 |
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
Topics: Adolescent; Adult; Blood Glucose; Carbon Monoxide; Diabetes Mellitus, Type 1; Female; Humans; Hypogl | 2004 |
22 other studies available for carbon monoxide and Autoimmune Diabetes
| Article | Year |
|---|---|
Biomimetic carbon monoxide nanogenerator ameliorates streptozotocin induced type 1 diabetes in mice.
Topics: Animals; Apoptosis; Biomimetics; Blood Glucose; Carbon Monoxide; Diabetes Mellitus, Experimental; Di | 2020 |
Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Autoimmunity; Carbon Monoxide; Caspase 3; Cell Line, T | 2014 |
Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy.
Topics: Adolescent; Biomarkers; Carbon Monoxide; Carboxyhemoglobin; Diabetes Mellitus, Type 1; Diabetic Neur | 2014 |
Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes.
Topics: Adiponectin; Animals; Aorta; Carbon Monoxide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2008 |
Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
Topics: Animals; Antioxidants; Boranes; Carbon Monoxide; Carbonates; Cyclic N-Oxides; Diabetes Mellitus, Exp | 2011 |
Pulmonary diffusing capacity for carbon monoxide: a marker of depressed hypercapnic drive in type 1 diabetes mellitus?
Topics: Adult; Autonomic Nervous System Diseases; Carbon Monoxide; Case-Control Studies; Diabetes Mellitus, | 2011 |
Impaired diffusing capacity for carbon monoxide in children with type 1 diabetes: is this the first sign of long-term complications?
Topics: Adolescent; Carbon Monoxide; Case-Control Studies; Child; Cohort Studies; Diabetes Complications; Di | 2012 |
Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes.
Topics: Animals; Autoantigens; Carbon Monoxide; CD8-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; | 2013 |
[Ventilatory mechanics and alveolo-capillary diffusion in diabetes].
Topics: Adolescent; Adult; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hu | 2002 |
Diffusing capacity for carbon monoxide in children with type 1 diabetes.
Topics: Adolescent; Carbon Monoxide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diffusion; Glycated | 2004 |
Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes.
Topics: Animals; Biliverdine; Carbon Monoxide; Cell Aggregation; Diabetes Mellitus, Experimental; Diabetes M | 2006 |
Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus.
Topics: Administration, Inhalation; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; H | 2006 |
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Carbon Monoxide; Diabetes Mellitus, | 2007 |
Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin.
Topics: Animals; bcl-X Protein; Bilirubin; Blood Glucose; Blotting, Western; Carbon Monoxide; CD11 Antigens; | 2007 |
Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Pressure; Carbon Monoxide; Diabetes Mellitus, Type 1; Drug Administration Schedule; Exe | 1997 |
Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease?
Topics: Adult; Aged; Blood Glucose; Breath Tests; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetes Melli | 1999 |
Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus.
Topics: Adult; Breath Tests; Carbon Dioxide; Carbon Monoxide; Diabetes Mellitus, Type 1; Dyspnea; Elasticity | 2000 |
Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose Self-Monitoring; Body Mass Index; Carbon Monoxide; Diabetes Mellitus, Type 1; F | 1991 |
Lung volume and distensibility in insulin-dependent diabetes mellitus.
Topics: Adult; Aging; Carbon Monoxide; Diabetes Mellitus, Type 1; Female; Humans; Lung; Lung Volume Measurem | 1991 |
Lung function in patients with diabetes mellitus.
Topics: Adult; Age Factors; Carbon Monoxide; Diabetes Mellitus, Type 1; Female; Forced Expiratory Volume; Hu | 1990 |
Is the carbon monoxide transfer factor diminished in the presence of diabetic retinopathy in patients with insulin-dependent diabetes mellitus?
Topics: Adult; Carbon Monoxide; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Forced Expiratory Volume; H | 1988 |
Pulmonary function in young insulin-dependent diabetic subjects.
Topics: Adolescent; Adult; Carbon Monoxide; Diabetes Mellitus, Type 1; Female; Humans; Lung; Lung Compliance | 1986 |